BUFFALO, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)SUNEEL RESEARCH FOUNDATION, founded in 2002, is a micro nonprofit in the Philanthropy & Grantmaking sector that reported $32K in total revenue in fiscal year 2024. Revenue fell 57% from the prior year — a significant decline worth monitoring. Expenses of $87K exceeded revenue, resulting in a 173% operating deficit.
THE FOUNDATION RAISES MONEY TO FOSTER AND ADVANCE MEDICAL AND SCIENTIFIC RESEARCH TO FIND A CURE FOR DUCHENNES MUSCULAR DYSTROPHY. IN ADDITION, THE FOUNDATION SEEKS TO PREVENT AND ALLEVIATE SUFFERING & PROMOTE EDUCATION & AWARENESS OF DUCHENNES MUSCULAR DYSTROPHY.
The Foundation funds research activities to find a cure for Duchennes Muscular Dystrophy (DMD). Currently there are a number of clinical trials underway for drugs developed to treat various aspects...
The Foundation funds research activities to find a cure for Duchennes Muscular Dystrophy (DMD). Currently there are a number of clinical trials underway for drugs developed to treat various aspects of DMD. In September 2016, Sarepta Therapeutics, won FDA approval for the use of its drug Exondys 51 for the treatment of DMD patients that have a confirmed mutation of the dystrophin gene amenable to exon 51 skipping. In December 2019, Sarepta, won FDA approval for its new drug Vyondys 53 for the treatment of patients that have a confirmed mutation of the dystrophin gene connected to exon 53 skipping. Both treatments help approximately 21% of the patients afflicted with DMD.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $31,942 | $75,087 | -0.6% |
| Expenses | $87,266 | $50,845 | +0.7% |
| Net Income | $-55,324 | $24,242 | -3.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| THOMAS A MAHER CPA | PRESIDENT | 10.00 |
Officer
Director
|
$0 | $0 | $0 |
| KENNETH MANNING ESQ | SECRETARY | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| NEERA GULATI MD | DIRECTOR | 5.00 |
Director
|
$0 | $0 | $0 |
| DAVID J KORZAK | DIRECTOR | 5.00 |
Director
|
$0 | $0 | $0 |
| WILLIAM CHRIST ESQ | DIRECTOR | 5.00 |
Director
|
$0 | $0 | $0 |
| GEORGE HAJDUCZOK ESQ | DIRECTOR | 5.00 |
Director
|
$0 | $0 | $0 |
| BENJAMIN B ROBERTS | DIRECTOR | 5.00 |
Director
|
$0 | $0 | $0 |
| GREGORY DIFRANCESCO MD | TREASURER | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $31,942 | $87,266 | $378,958 | $-55,324 |
| 2023 | $75,087 | $50,845 | $434,282 | $24,242 |
| 2022 | $36,380 | $97,643 | $410,040 | $-61,263 |
| 2021 | $24,017 | $20,825 | $471,303 | $3,192 |
| 2020 | $25,360 | $25,315 | $468,111 | $45 |
| 2019 | $37,103 | $49,317 | $468,066 | $-12,214 |
| 2018 | $72,885 | $45,588 | $480,280 | $27,297 |
Compare SUNEEL RESEARCH FOUNDATION with other nonprofits in New York and across the country.